The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: A randomised, placebo controlled study in volunteers

Gut

Volumn 41, Issue 6, 1997, Pages 758-762

  Van Berge Henegouvven, M I ^a   Van Gulik, Th M ^a   Akkermans, L M A ^b   Jansen, J B M J ^c   Gouma, D J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cholecystokinin; Gastric emptying; Intestinal transit; Octreotide; Pancreatic surgery

Indexed keywords

OCTREOTIDE;

ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HOSPITALIZATION; HUMAN; MALE; NORMAL HUMAN; PANCREAS SECRETION; PANCREAS SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH EMPTYING;

EID: 0031465746     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.6.758     Document Type: Article

References (50)

1. Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, et al. A prospective randomized trial of pancreticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 1995;222:580-8.
2. Zerbi A, Balzano G, Patuzzo R, Calori G Braga M, Di Carlo V. Comparison between pylorus-preserving and Whipple pancreatoduodenectomy. Br J Surg 1995;82:975-9.
3. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-live consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217:430-5.
4. Klinkenbijl JH, van der Schelling GP, Hop WC, van Pel R, Bruining HA, Jeekel J. The advantages of pyloruspreserving pancreatoduodenectomy in malignant disease of the pancreas and periampullary region. Ann Surg 1992; 216:142-5.
5. Miedema BW, Sarr MG, van Heerden JA, Nagorney DM, Mcllrath DC, Ilstrup D. Complications following pancreaticoduodenectomy. Current management. Arch Surg 1992; 127:945-9.
6. Trede M, Schwall G. The complications of pancreatectomy. Ann Surg 1988;207:39-47.
7. Braasch JW, Gray BN. Considerations that lower pancreatoduodenectomy mortality. Am J Surg 1977;133:480-4.
8. Buchler M, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992;163:125-30.
9. Pederzoli P, Bassi C, Falconi M, Camboni MG. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 1994;81: 265-9.
10. Friess H, Beger HG, Sulkowski U, Becker H, Hofbaucr B, Dennler HJ, et al. Randomized controlled multicentrc study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 1995;82:1270-3.
11. Montorsi M, Zago M, Mosca F, Capussotti L, Zotti E, Ribotta G, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 1995;117:26-31
12. Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut 1994;35: S1-4.
13. Kutz K, Nuesch H, Rosenthaler J. Pharmacokinetics of SMS 201 995 in healthy subjects. Scand J Gastroenterol 1986; 119:65-72.
14. Gyr KE, Meier R. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract. Digestion 1993;54(suppl 1):14-9.
15. Stolk MF, van Erpecum KJ, Koppeschaar HP, de Bruin WI, Jansen JB, Lamers CB, et al. Postprandial gallbladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly. Gut 1993;34:808-13.
16. Liberski SM, Koch KL, Atnip RG, Stern RM. Ischemic gastroparesis: resolution after revascularization. Gastroenterology 1990;99:252-7.
17. Hunt DR, McLean R. Pylorus-preserving pancreatectomy: functional results. Br J Surg 1989;76:173-6.
18. Hocking MP, Harrison WD, Sninsky CA. Gastric dysrhythmias following pylorus-preserving pancreaticoduodenectomy. Possible mechanism for early delayed gastric emptying. Dig Dis Sci 1990;35:1226-30.
19. Tanaka M, Sarr MG. Effects of exogenous motilin and morphine on interdigestive gastrointestinal motor activity after total duodenectomy in dogs. Surgery 1998;104:317-25.
20. Tanaka M, Sarr MG. Role of the duodenum in the control of canine gastrointestinal motility. Gstroenterology 1988; 94:622-9.
21. Tanaka M, Sarr MG. Total duodenectomy: effect on canine gastrointestinal motility. J Surg Res 1987;42:483-93.
22. Nelson-Piercy C, Haminond PJ, Gwilliam ME, KhandanNia N, Myers MJ, Ghatei MA, et al. Effect of a new oral somatostatin analog (SDZ CO 611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects. J Clin Endocrinol Metab 1994;78:329-36.
23. Fuessl HS, Carolan G, Williams G, Bloom SR. Effect of a long-acting somatostatin analogue (SMS 201 995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion 1987;36: 101-7.
24. von der Ohe MR, Camilleri M, Thomforde GM, Klee GG. Differential regional effects of octreotide on human gastrointestinal motor function. Gut 1995;36:743-8.
25. Huruma K, Wiste JA, Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut 1994;35:1064-9.
26. Vecht J, van der Kleij F, Lamers CBHW, Masclee AAM. Effect of octreotide on small intestinal motility and transit time in the fasting and the fed state [abstract]. Neth J Med 1994;44:A33.
27. Cullen JJ, Eagon JC, Dozois EJ, Kelly KA. Treatment of acute postoperative ileus with octreotide. Am J Surg 1993; 165:113-9.
28. Wald A, Van Thiel DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981;80:1497-500.
29. Notivol R, Carrio I, Cano L, Estorch M, Vilardell F. Gastric emptying of solid and liquid meals in healthy young subjects. Scand J Gastroenterol 1984;19:1107-13.
30. Horowitz M, Maddem GJ, Chatterton BE, Collins PJ, Petrucco OM, Seamark R, et al. The normal menstrual cycle has no effect on gastric emptying. Br J Obstet Gynaecol 1985;92:743-6.
31. Gill RC, Murphy PD, Hooper HR, Bowes KL, Kingma YJ. Effect of the menstrual cycle on gastric emptying. Digestion 1987;36:168-74.
32. Petring OU, Flachs H. Inter- and intrasubject variability of gastric emptying in healthy volunteers measured by scintigraphy and paracetamol absorption. Br J Clin Pharmacol 1990;29:703-8.
33. Mangnall YF, Kerrigan DD, Johnson AG, Read NW. Applied potential tomography. Noninvasive method for measuring gastric emptying of a solid test meal. Dig Dis Sci 1991;36:1080-4.
34. Avili R, Mangnall YF, Bird NC, Brown BH, Barber DC, Seagar AD, et al. Applied potential tomography. A new noninvasive technique for measuring gastric emptying. Gastroenterology 1987;92:1019-26.
35. Tjeerdsma HC, Smout AJ, Akkermans LM. Voluntary suppression of defecation delays gastric emptying. Dig Dis Sci 1993;38:832-6.
36. Mushambi MC, Trotter TN, Barker P, Rowbotham DJ. A comparison of gastric emptying rate after cimetidine and ranitidine measured by applied potential tomography. Br J Clin Pharmacol 1992;34:278-80.
37. Forrest JA, Pertes MR, McLoughlin GP, Heading RC. Effect of long-term cimetidine on gastric acid secretion, serum gastrin, and gastric emptying. Gut 1979;20:404-7.
38. Jansen JB, Lamers CB. Radioimmunoaissay of cholecystokinin in human tissue and plasma. Clin Chim Acta 1983;131: 305-16.
39. Baxter AJ, Mangnall YF, Loj EH, Brown B, Barber DC, Johnson AG, et al. Evaluation of applied potential tomography as a new non-invasive gastric secretion test. Gut 1988; 29:1730-5.
40. Friess H, Bordihn K, Ebert M, Malfertheiner P, KemmerT, Dennler HJ, et al. Inhibition of pancreatic secretion under long-term octreotide treatment in humans. Digestion 1994; 55(suppl 1);10-5.
41. Heddle R, Collins PJ, Dent J, Horowitz M, Read NW, Chatterton B, et al. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion. J Gastroenterol Hepatol 1989;4:437-47.
42. Heddle R, Dent J, Read NW, Houghton LA, Toouli J, Horowitz M, et al. Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers. Am J Pysiol 1988;254:G671-9.
43. Walsch JH, Mayer EA. Gastrointestinal hormones. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal discase. Philadelphia: Saunders, 199:18-38.
44. Konturek JW, Thor P, Maczka M, Stoll R, Domschke W, Konturek SJ. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients. Scand J Gastroenterol 1994;29:583-90.
45. Debas HT, Farooq O, Grossman MI. Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology 1975;68:1211-7.
46. Kleibeuker JH, Beekhuis H, Jansen JB, Piers DA, Lamers CB. Cholecystokinin is a physiological hormonal mediator of fat-induced inhibition of gastric emptying in man. Eur J Clin Invest 1988;18:173-7.
47. Fraser R, Fone D, Horowitz, M, Dent J. Cholecystokinin octapeptide stimulates phasic and tonic pyloric motility in healthy humans. Gut 1993;34:33-7.
48. Lembcke B, Creutzfeldt W Sehleser S, Ebert R, Shaw C, Koop I. Effect of the somatostatin analogue sandostatin (SMS 201 995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987;36:108-24.
49. Reichlin S. Somatostatin. N Engl J Med 1983;309:1556-63.
50. Creutzfeldt W, Lembcke B, Folsch UR, Schleser S, Koop I. Effect of somatostatin analogue (SMS 201 995, Sandostatin) on pancreatic secretion in humans. Am J Med 1987;82: 49-54.